Jasper Therapeutics: Funding, Investors & Team (Sep 2026)
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and gene therapies. The company s novel engineered hematopoietic stem cells (eHSCs) platform aims to overcome the limitations of transplant grafts while also unlocking the potential of stem cells, potentially increasing the number of patients who could benefit from allogeneic and autologous gene-edited hematopoietic stem cell therapy. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
Jasper Therapeutics has raised $140M across 2 funding rounds on record, the most recent an undisclosed round of $50.0M announced in Feb 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Jasper Therapeutics Company Profile and Key Stats
Latest funding round on record: Feb 2024.
Jasper Therapeutics Funding Rounds
Jasper Therapeutics raised $90.0M in an undisclosed round announced in Jan 2023.
1.1 years later, an undisclosed round of $50.0M was announced in Feb 2024.
Jasper Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Jasper Therapeutics Funding Compared to Other Biotechnology Startups
Jasper Therapeutics' latest round of $50.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Jasper Therapeutics in Biotechnology and Redwood City
Companies Similar to Jasper Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Jasper Therapeutics Funding FAQs
What does Jasper Therapeutics do?
Jasper is a biotechnology company focused on enabling safer conditioning agents to allow for the expanded use of curative therapy with stem cell transplants and gene therapies. The company s novel engineered hematopoietic stem cells (eHSCs) platform aims to overcome the limitations of transplant grafts while also unlocking the potential of stem cells, potentially increasing the number of patients who could benefit from allogeneic and autologous gene-edited hematopoietic stem cell therapy. Jasper’s lead compound, JSP191, is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients undergoing a stem cell transplant.
How much funding has Jasper Therapeutics raised?
Jasper Therapeutics has raised $140M across 2 rounds on record. The most recent is an undisclosed round of $50.0M announced in Feb 2024.
When did Jasper Therapeutics last raise funding?
Jasper Therapeutics' most recent funding round on record is an undisclosed round of $50.0M, announced in Feb 2024.
Who founded Jasper Therapeutics?
FundedIQ lists Judith Shizuru Md (Founder), Susan Prohaska (Founder) at Jasper Therapeutics.
Where is Jasper Therapeutics headquartered?
Jasper Therapeutics is based in Redwood City, California, United States.
How many employees does Jasper Therapeutics have?
Jasper Therapeutics is in the 51-100 employee band.
How does Jasper Therapeutics' funding compare to other Biotechnology startups?
Jasper Therapeutics' latest round of $50.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Jasper Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Jasper Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.